RA
Rupawali Agrawal
About Rupawali Agrawal
Data last updated:
Rupawali Agrawal is a Director at Rabhiaans Biotech Private Limited (since 2019), Director at Manomay Life Care Private Limited (since 2020) and Director at Frenklomed Pharmaceuticals Private Limited (since 2021). The companies operate in Food And Beverages, Home Appliances and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹2.14 Cr; the largest is Rabhiaans Biotech Private Limited at ₹1.65 Cr (FY 2024). Earlier, Rupawali Agrawal was a Director at Ravian Formulation Private Limited (2015–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Aug 2019 | 2019 | ₹1.65 Cr (FY 2024) | Active | |
| Director | 19 Aug 2020 | 2014 | ₹48.7 Lakh (FY 2025) | Active | |
| Director | 25 Mar 2021 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rupawali Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Surendra Kumar | 06830651 | Rabhiaans Biotech Private Limited , Manomay Life Care Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupawali Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupawali Agrawal
Rupawali Agrawal currently holds 3 directorships: Rabhiaans Biotech Private Limited (Director, since 05 Aug 2019, revenue ₹1.65 Cr (FY 2024)); Manomay Life Care Private Limited (Director, since 19 Aug 2020, revenue ₹48.7 Lakh (FY 2025)); Frenklomed Pharmaceuticals Private Limited (Director, since 25 Mar 2021).
Rupawali Agrawal was first appointed on 25 Mar 2015 as Director at Ravian Formulation Private Limited. The most recent appointment on record is 25 Mar 2021 at Frenklomed Pharmaceuticals Private Limited.
The 2 current companies of Rupawali Agrawal that report revenue have a combined latest revenue of ₹2.14 Cr: Rabhiaans Biotech Private Limited ₹1.65 Cr (FY 2024); Manomay Life Care Private Limited ₹48.7 Lakh (FY 2025).
Rupawali Agrawal held 1 earlier board appointment: Ravian Formulation Private Limited (Director, 25 Mar 2015 to 23 Feb 2019).
The current boards of Rupawali Agrawal's companies include Surendra Kumar (Rabhiaans Biotech Private Limited).